Skip Navigation
Narrow By
Clinical Areas
< All
1 - 20 of 502
STUDY
Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions.
Lehmann LS, Puopolo AL, Shaykevich S, Brennan TA. Am J Med. 2005;118:409-413.
COMMENTARY
Smart pumps: advanced capabilities and continuous quality improvement.
Vanderveen T. Patient Saf Quality Healthc. January/February 2007.
STUDY
Risk of adverse drug events in neonates treated with opioids and the effect of a bar-code–assisted medication administration system.
Morriss FH, Jr, Abramowitz PW, Nelson SP, Milavetz G, Michael SL, Gordon SN. Am J Health Syst Pharm. 2011;68:57-62.
MULTI-USE WEBSITE
Medical Event Data Collection and Analysis Service (MEDCAS).
Cognitive Technologies Laboratory, University of Chicago.
STUDY
Intensive care unit safety incidents for medical versus surgical patients: a prospective multicenter study.
Sinopoli DJ, Needham DM, Thompson DA, et al. J Crit Care. 2007;22:177-183.
STUDY
Maintaining and sustaining the On the CUSP: Stop BSI model in Hawaii.
Lin DM, Weeks K, Holzmueller CG, Pronovost PJ, Pham JC. Jt Comm J Qual Patient Saf. 2013;39:51-60.
STUDY
Provider and pharmacist responses to warfarin drug–drug interaction alerts: a study of healthcare downstream of CPOE alerts.
Miller AM, Boro MS, Korman NE, Davoren JB. J Am Med Inform Assoc. 2011;18(suppl 1):i45-i50.
STUDY
Eradicating central line–associated bloodstream infections statewide: the Hawaii experience.
Lin DM, Weeks K, Bauer L, et al. Am J Med Qual. 2012;27:124-129.
STUDY
Intensive care unit readmissions in U.S. hospitals: patient characteristics, risk factors, and outcomes.
Kramer AA, Higgins TL, Zimmerman JE. Crit Care Med. 2012;40:3-10.
STUDYclassic
Intervention to reduce transmission of resistant bacteria in intensive care.
Huskins WC, Huckabee CM, O'Grady NP, et al; STAR*ICU Trial Investigators. N Engl J Med. 2011;364:1407-1418.
STUDY
Adverse drug event reporting in intensive care units: a survey of current practices.
Kane-Gill SL, Devlin JW. Ann Pharmacother. 2006;40:1267-73.
STUDY
Cost implications of actual and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Am J Health Syst Pharm. 2007;64:2483-2487.
STUDY
Multiprofessional survey of protocol use in the intensive care unit.
LeBlanc JM, Kane-Gill SL, Pohlman AS, Herr DL. J Crit Care. 2012;27:738.e9-738.e17.
STUDY
Medication-error reporting and pharmacy resident experience during implementation of computerized prescriber order entry.
Weant KA, Cook AM, Armitstead JA. Am J Health Syst Pharm. 2007;64:526-530.
STUDY
Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events.
Nuckols TK, Bower AG, Paddock SM, et al. J Gen Intern Med. 2008;23(suppl 1):41-45.
STUDY
Analysis of risk factors for adverse drug events in critically ill patients.
Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM. Crit Care Med. 2012;40:823-828.
COMMENTARY
Creating the web-based intensive care unit safety reporting system. 
Holzmueller CG, Pronovost PJ, Dickman F, et al. J Am Med Inform Assoc. 2005;12:130-139.
REVIEW
Computerized physician order entry in the critical care environment: a review of current literature.
Maslove DM, Rizk N, Lowe HJ. J Intensive Care Med. 2011;26:165-171.
1 2 3 4 5 6 7 8 9 10 11Next >